Can-Fite BioPharma Ltd. Quarterly Contract with Customer, Liability, Current in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Can-Fite BioPharma Ltd. quarterly Contract with Customer, Liability, Current history and growth rate from Q4 2022 to Q4 2023.
  • Can-Fite BioPharma Ltd. Contract with Customer, Liability, Current for the quarter ending December 31, 2023 was $622K, a 20.6% decline year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $622K -$161K -20.6% Dec 31, 2023 20-F 2024-03-28
Q4 2022 $783K Dec 31, 2022 20-F 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.